WhatFinger

FDA Restricts Use of 2 Monoclonal Antibody Treatments

By Epoch Times ——--January 25, 2022

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us

The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal antibody treatments for COVID-19, saying data show such treatments are “highly unlikely” to be active against the Omicron variant, currently the dominant strain in the country. Monoclonal antibodies are laboratory-created proteins that mimic natural antibodies the body produces to fight off harmful pathogens, such as the CCP (Chinese Communist Party) virus, also known as the novel coronavirus.-- More...

Support Canada Free Press

Donate
Subscribe

View Comments
Epoch Times——

The Epoch Times: “A Fresh Look at Our Changing World”

The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.

 

We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.

VIEW Comments

Sponsored
!-- END RC STICKY -->